Sbir phase i: phage-amplified identification and antimicrobial susceptibility test

Cobio Diagnostics Inc. received a $256,000 Project Grant award from the National Science Foundation on April 1, 2021 to support work concluding on March 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and education.

Specifically, the grant funds Cobio Diagnostics' "SBIR PHASE I: PHAGE-AMPLIFIED IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TEST" project. This work appears to involve developing phage-based methods for identifying microbes and testing their susceptibility to antimicrobials. Such techniques could potentially help address the need for rapid and accurate diagnostic tools mentioned in the program description. The 12-month period and award amount of $256K suggest the company will work to validate these phage-based approaches and lay the groundwork for further development.